Statistics

Total Visits

Views
Bosutinib shows low cross intolerance, in chronic myeloid leukemia patients treated in fourth line. Results of the Spanish compassionate use program127

Select a period of time:

Number of views in the range

Views
Bosutinib shows low cross intolerance, in chronic myeloid leukemia patients treated in fourth line. Results of the Spanish compassionate use program43

Views

Views
December 20251
January 202615
February 20261
March 20266
April 20260
May 20266
June 202614
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States21
United Kingdom7
Netherlands3
Spain3
Canada2
Argentina1
Australia1
China1
Ecuador1
Ethiopia1
 

Top cities views

Views
San Jose10
Greenwich4
Groningen3
A Coruña2
Addis Ababa1
Basingstoke1
Bergenfield1
Brooklyn1
Cuenca1
Fredericton1